AI Driven Bloodless Blood Tests Sean (Shunsuke) Matsuoka, Co-Founder & COO, GPx GPx: https://gpx.ai/
In an aging society, the number of heart failure patients is increasing, making the prevention of readmissions and reduction of medical costs critical issues. Remote monitoring using invasive implantable devices has proven effective in reducing heart failure readmissions, but its use remains limited.
To address this, GPx has developed an algorithm that non-invasively predicts signs of heart failure exacerbation. This algorithm was created using clinical trial data from monitoring 245 heart failure patients over 6 months to a year at eight facilities, including the Mayo Clinic in the U.S. The algorithm links digital biomarker data with vital blood tests (NT-proBNP and creatinine) to achieve high-precision prediction and early medical intervention.
Additionally, with a grant of 1.2 billion yen provided through AMED, we are collaborating with the National Cerebral and Cardiovascular Center (Dr. Chisato Izumi) to conduct a clinical trial involving 400 patients starting April 2025. The trial will be conducted at the National Cerebral and Cardiovascular Center, Kyoto University, Kobe University, and Kochi University.
Furthermore, at this year's MIT Japan Conference, we will unveil a groundbreaking point-of-care (POC) potassium testing device for the first time. At the conference, we aim to explore the feasibility of applying our technology to other conditions (such as kidney failure, pulmonary arterial hypertension, and cardio-oncology) and to assess the potential for providing algorithm-based services for heart failure patients within Japan.
Looking for 8-10 startups to present their tech on May 5 at the 2022 MIT Efficient AI and Computing Technologies Conference.
MIT Startup Exchange is looking for 6 startup speakers for the StartUP@MTL event, which will run virtually on Thursday, April 7, noon – 2pm ET.
MIT Startup Exchange is looking for 3-4 startup speakers to participate in a pre-recorded webcast on April 29 and a possible follow-up live event on May 4, both focused on work of the future.
Japanese multinational company looking globally for startups to collaborate with in the field of energy storage and related battery systems.
Apply for the 2025 Sloan Healthcare Innovation Prize. Do you have an innovative solution to a problem in healthcare or biotech? We are now accepting applications to the Sloan Healthcare Innovation Prize Competition.
The 2024 MIT Health Science Technology Conference will highlight broad and transformative trends in biology and healthcare, including early-stage discovery, immune cell responses, diagnostics, clinical capabilities, process development, rapid and continuous manufacturing, robotics and automation, and sustainability, all enhanced by artificial intelligence and machine learning technologies. Leading MIT researchers and MIT-connected startups will showcase these advances and discuss their implications for improving human health.
Synthetic Biology Workshop 2017 - Panel Discussion
P&G and AS Watson are looking for startup partnerships to build new, personalized, effortless, and cost-effective ways to enhance the overall shopper experience Online + Offline through the Guided Selling Challenge and the Social Commerce Challenge.